2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Lung Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Breast Neoplasms
6
Head and Neck Neoplasms
4
Uterine Cervical Neoplasms
3
Tobacco Use Disorder
3
Small Cell Lung Carcinoma
3
Obesity
3
cyclopia sequence
2
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Smoking Cessation
2
Pancreatic Neoplasms
2
Overweight
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Nasopharyngeal Neoplasms
2
Mouth Neoplasms
2
Liver Neoplasms
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Laryngeal Neoplasms
2
Kidney Neoplasms
2
Hypopharyngeal Neoplasms
2
Esophageal Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Hepatocellular
2
Advanced Solid Tumor
2
Vulvar Neoplasms
1
Interventions
bisaramil
1
Varenicline
1
Tobacco Use Cessation Devices
1
Surveys and Questionnaires
1
Nicotine Chewing Gum
1
Moclobemide
1
Methods
1
Escitalopram
1
Early Intervention, Educational
1
Bupropion
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Behavior, Addictive
×
Bupropion
×
Clear all
NCT04634071
2026-02-02
TTOP
University of Kentucky
Phase 2
Completed
126 enrolled